These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7744699)

  • 21. A carboxy-terminal mutant spleen focus-forming virus (SFFV) envelope glycoprotein is transport-competent, but non-leukemogenic.
    Srinivas RV; Rui Z; Compans RW
    Virus Res; 1992 Oct; 26(1):57-69. PubMed ID: 1441737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family.
    Hoatlin ME; Gomez-Lucia E; Lilly F; Beckstead JH; Kabat D
    J Virol; 1998 May; 72(5):3602-9. PubMed ID: 9557641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular transport and leukemogenicity of spleen focus-forming virus envelope glycoproteins with altered transmembrane domains.
    Srinivas RV; Kilpatrick DR; Compans RW
    J Virol; 1987 Dec; 61(12):4007-11. PubMed ID: 2824830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease.
    Umehara D; Watanabe S; Ochi H; Anai Y; Ahmed N; Kannagi M; Hanson C; Ruscetti S; Nishigaki K
    J Virol; 2010 Aug; 84(15):7675-82. PubMed ID: 20504929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J; Ung Y; Adachi D; Ben-David Y
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk.
    Nishigaki K; Hanson C; Jelacic T; Thompson D; Ruscetti S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15488-93. PubMed ID: 16223879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
    Lin TS; Ishiguro K; Sartorelli AC
    Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequences of polycythemia-type Friend spleen focus-forming virus in clone-745-derived mouse erythroleukemia cells.
    Scher W; Jing Y; Lu M; Bishop DF; Scher BM
    Arch Virol; 2009; 154(5):895-8. PubMed ID: 19347245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55.
    Li JP; Hu HO; Niu QT; Fang C
    J Virol; 1995 Mar; 69(3):1714-19. PubMed ID: 7853508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired activation and binding of the erythropoietin receptor by a mutant gp55 of Friend spleen focus-forming virus, which has a cytoplasmic domain.
    Yugawa T; Amanuma H
    Virology; 1998 Jul; 246(2):232-40. PubMed ID: 9657942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
    Subramanian A; Hegde S; Correll PH; Paulson RF
    Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53.
    Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M
    Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cis-Active elements of Friend spleen focus-forming virus: from disease induction to disease prevention.
    Baum C; Hunt N; Hildinger M; Eckert HG; Zaehres H; Richters A; John J; Löhler J; Ostertag W
    Acta Haematol; 1998; 99(3):156-64. PubMed ID: 9587397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
    J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation of Stat-related DNA-binding proteins in erythroid cells by the Friend spleen focus-forming virus.
    Ohashi T; Masuda M; Ruscetti SK
    Leukemia; 1997 Apr; 11 Suppl 3():251-4. PubMed ID: 9209356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of a novel spleen focus-forming virus-specific glycoprotein (gp51) in a Friend leukemia cell line and its decrease during erythrodifferentiation.
    Matsugi T; Amanuma H; Ikawa Y
    Gan; 1983 Aug; 74(4):509-16. PubMed ID: 6628903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
    Li JP; D'Andrea AD; Lodish HF; Baltimore D
    Nature; 1990 Feb; 343(6260):762-4. PubMed ID: 2154701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
    Lavigueur A; Bernstein A
    Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.